We sought to create and characterize a mouse model of cALD that facilitate the study of disease pathogenesis and therapy development. We also sought to cross-validate two potential therapeutic targets, fibrinogen and NLRP3 inflammasome activation pathways in cALD postmortem humans' brain tissues and cALD mouse model.
No takes yet. Share an insight, caveat, or question.
Hashemi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: